Blocknomi
Key Takeaways SELLAS Life Sciences (SLS) shares have surged 255% in 2025 as investors anticipate crucial Phase 3 REGAL trial results for galinpepimut-S in acute myeloid leukemia patients The clinical…
Related articles
-
Ripple Exec: Clarity Act Can Unlock More US Jobs
U.Today Published 30.08.2026 18:52
-
What Would XRP Be Worth at a $500 Billion Market Cap? The Answer May Surprise You
CryptoPotato Published 29.08.2026 04:00
-
Donald Trump Jr.’s 1789 Capital to Put $300M Into Polymarket
CryptoPotato Published 01.09.2026 08:48
-
Franklin Templeton Eyes ETFs for Tokenized Money Market Fund
Blocknomi Published 20.08.2026 18:05
-
Aligned Launches $ALIGN, the Native Token of Its Full Ethereum Stack
BlockchainReporter Published 20.08.2026 17:29
-
Zcash (ZEC) Could Hit $8,100 by 2030 as Grayscale Debuts First U.S. Spot ETF
Blocknomi Published 27.08.2026 06:08
-
Anthropic Admits Security Failures Behind Claude Hacking Incidents
Decrypt Published 02.09.2026 23:46
-
Metaplanet Puts 2,100 BTC Into Super League for US Expansion
Bitcoin.com Published 20.08.2026 07:30